VARON Celebrates Older Americans Month by Supporting Healthy Aging and Independence
NEW YORK, May 14, 2026 /PRNewswire/ -- This May, in honor of Older Americans Month, VARON, a leading provider of oxygen and respiratory care solutions, is highlighting the importance of wellness, independence, and quality of life for older adults through reliable oxygen concentrator machine solutions designed for everyday use. Older Americans Month, recognized annually in the United States, celebrates the...
Applications Open for Second Annual Asia-Pacific Global Health Innovation Hackathon on Maternal & Child Nutrition
12 teams, 48 Hours. Innovating for a healthier, more equitable Asia-Pacific SINGAPORE, May 14, 2026 /PRNewswire/ -- Applications are now open for the second annual Asia-Pacific Global Health Innovation Hackathon, to be held in Singapore on 18–19 September 2026. Jointly co-hosted by two SingHealth Duke-NUS Academic Medical Centre institutes, the Academic Medicine Innovation Institute (AMII) and the Global Health Institute...
So-Young to Report First Quarter 2026 Financial Results on May 22, 2026
BEIJING, May 14, 2026 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that it will report its financial results for the first quarter ended March 31, 2026, before U.S. markets open on May 22, 2026. So-Young's management will...
Breakthrough skin-tightening device XERF™ arrives in Australia
The new radiofrequency treatment, XERF, is designed to target multiple layers of the skin while prioritizing patient comfort. SYDNEY, May 14, 2026 /PRNewswire/ -- Cynosure Lutronic's XERF is a radiofrequency-based treatment designed to tighten and revitalise skin without the need for needles, numbing or downtime. Positioned as the world's first single-shot, multifrequency monopolar RF technology, XERF combines 6.78 MHz...
Wellcome launches world’s largest global prize for mental health science
The prize, in partnership with Nature, will celebrate breakthroughs in mental health science. It aims to accelerate translation, influence policy and transform lives This award champions new pharmacological, psychological, social and digital interventions from around the world The overall winner will receive USD 1 million, and three finalists will be awarded USD...
SingPost and Fullerton Health to Collaborate on Healthcare Logistics and Last-Mile Medical Delivery
SINGAPORE, May 14, 2026 /PRNewswire/ -- Singapore Post Limited ("SingPost") and Fullerton Healthcare Group Private Limited ("Fullerton Health") have today announced the signing of a Memorandum of Understanding ("MOU") to explore the co-development of a robust, integrated healthcare delivery ecosystem. (Left to right) Mark Chong, Chief Executive Officer, SingPost; Andy Lim, Head of Commercial, SingPost; Derrick Chan, Managing...
GenesisCare and SeeTreat to bring personalised Offline Adaptive Monitoring to more than 40 radiation oncology centres across Australia
SYDNEY, May 14, 2026 /PRNewswire/ -- Leading Australian cancer care provider, GenesisCare, is pleased to be collaborating with SeeTreat to enable suitable cancer patients access to the latest technology in offline adaptive treatment assessment. SeeTreat's ART.1 software will be rolled out at GenesisCare from July 2026 to support automated, adaptive treatment evaluation for eligible patients. ...
EBT Medical and NinaMED Announce US$13.75M Financing to Advance Licensed NiNA System® for Overactive Bladder
US$13.75M financing completed to accelerate clinical pathway and global commercialisation Establishment of NinaMED Pty Ltd, a new Australian medtech company NinaMED Pty Ltd secures a license from EBT Medical for exclusive global rights to NiNA System®, a non‑invasive, at‑home OAB therapy targeting a 550 million‑patient market with a drug‑free alternative NinaMED Board chaired by Ian Meredith, bringing world‑class...
MEDIPOST’s CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control
- Achieved statistical significance versus standard-of-care (SOC) control across all key efficacy endpoints in the 52-week study- Japan Phase 3 results strengthen CARTISTEM's® global commercial prospects, with Japan biologics license application (BLA) scheduled for 2H 2026 SEOUL, South Korea and TOKYO, May 14, 2026 /PRNewswire/ -- MEDIPOST has met all primary and secondary efficacy endpoints in the Japan...
METiS TechBio, the World’s First Publicly Listed AI-Powered Drug Delivery Company, Debuts on the Hong Kong Stock Exchange, “The SpaceX of Pharmaceuticals” Ushers in a New Era of Biopharmaceuticals
HONG KONG, May 14, 2026 /PRNewswire/ -- METiS TechBio (7666.HK), a tech-bio company focused on AI-powered nanodelivery innovation, today successfully listed on the Hong Kong Stock Exchange (HKEX), becoming the world's first publicly listed AI-powered drug delivery company and the first AI-powered large-molecule biopharmaceutical company listed on the Hong Kong market. With...
